Educational Objectives

By the end of the 4-day educational programme, the participants will be able to:

  • appreciate the epidemiological impact of thrombosis and venous thromboembolism (VTE)
  • translate the knowledge from experimental research to the pathogenesis of acute and chronic VTE, including VTE associated with COVID-19
  • understand the association between thrombosis and cancer, and its implications for clinical practice
  • employ scores and prediction rules in the diagnosis of VTE
  • discover the remaining grey zones in severity assessment of acute pulmonary embolism (PE)
  • set the indications for advanced therapy in PE presenting with acute right heart failure (thrombolysis, catheter-directed treatment, circulatory support)
  • determine the appropriate management strategy in challenging cases and vulnerable patient populations, including VTE in pregnancy
  • gain deeper insight into the modalities, duration, and possible complications of anticoagulation
  • learn about the next-generation anticoagulant drugs, currently in the phase of development or clinical testing
  • implement guideline recommendations to the early detection, diagnosis and treatment of chronic thromboembolic pulmonary hypertension
  • correctly perform and interpret cardiac and vascular ultrasound as well as right heart catheterization
  • evaluate the design and interpret the statistical analysis of clinical trials
  • network with international experts and early-stage researchers/physicians in the field of thrombosis and venous thromboembolism.